“小单位”如何实现“大作为”？一支药监新军的“十四五”答卷

Core Viewpoint - The establishment of the Qingyang Law Enforcement Inspection Bureau represents a significant step towards enhancing drug safety and regulatory efficiency in the Gansu province, evolving from integration to a more cohesive and demonstrative regulatory approach [1][2]. Group 1: Organizational Development - The Qingyang Law Enforcement Inspection Bureau was created to address the challenges of limited personnel and extensive regulatory tasks, aiming for a significant impact despite being a small unit [2]. - The leadership has implemented a "Four No Distinctions" principle in personnel selection, focusing solely on capability and contribution, which has fostered a collaborative and resilient team [2]. Group 2: Regulatory Framework - The bureau has developed a systematic approach to drug regulation, moving away from traditional methods to a structured framework that emphasizes training, thorough preparation, and a closed-loop process for inspections [4]. - A collaborative mechanism has been established with local market regulatory bodies to enhance information sharing and create a comprehensive regulatory network across cities and counties [4]. Group 3: Performance and Impact - The bureau has conducted over ten special inspections during the "14th Five-Year Plan" period, identifying and rectifying more than a thousand risk issues, and has handled 26 legal cases, including seven with penalties exceeding 100,000 yuan [5]. - The implementation of a "risk + credit" dual evaluation system has significantly improved the compliance levels of local pharmaceutical companies [5]. Group 4: Service Orientation - The bureau emphasizes a service-oriented approach to law enforcement, providing tailored support to enterprises and ensuring 100% compliance with quality control systems [5]. - Initiatives have led to the approval of 13 new products by a local pharmaceutical company, accounting for 72% of the province's new approvals during the "14th Five-Year Plan" [5]. Group 5: Recognition and Future Outlook - The bureau's regulatory practices have received recognition from various media outlets, highlighting its journey from inception to excellence [7]. - Future plans include strengthening regulatory effectiveness, promoting corporate responsibility, and enhancing community involvement in drug safety [7].